Article

Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure

Department of Surgery, University of Michigan Health System, Ann Arbor, MI, USA.
Critical care medicine (Impact Factor: 6.15). 04/2010; 38(4 Suppl):e74-90. DOI: 10.1097/CCM.0b013e3181cc5373
Source: PubMed

ABSTRACT Severe respiratory failure (including acute lung injury and acute respiratory distress syndrome) caused by 2009 H1N1 influenza infection has been reported worldwide. Refractory hypoxemia is a common finding in these patients and can be challenging to manage. This review focuses on nonventilatory strategies in the advanced treatment of severe respiratory failure and refractory hypoxemia such as that seen in patients with severe acute respiratory distress syndrome attributable to 2009 H1N1 influenza. Specific modalities covered include conservative fluid management, prone positioning, inhaled nitric oxide, inhaled vasodilatory prostaglandins, and extracorporeal membrane oxygenation and life support. Pharmacologic strategies (including steroids) investigated for the treatment of severe respiratory failure are also reviewed.

1 Follower
 · 
170 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pandemic influenza: intensive care management of adults and children The clinical course of pandemic H1N1 infection has been quite different from seasonal influenza in- fection. It has mostly affected young and healthy population. Depending on outbreak's course till to- day and the previous outbreaks 12-30% of the population was expected to become ill and among them 4% was expected to be hospitalised throughout the pandemic. It was estimated for all inten- sive care unit (ICU) beds to be occupied with patients infected with H1N1 virus in the first period of the pandemic. Fortunately, without being confronted with this situation, pandemic has been mil- der than expected. Any how, in southern hemisphere as in Australia and New Zeland which were
  • [Show abstract] [Hide abstract]
    ABSTRACT: Extracorporeal membrane oxygenation (ECMO) is recommended as a treatment modality for severe acute respiratory distress syndrome (PaO2/FiO2 ≤ 100 mm Hg with positive end-expiratory pressure ≥ 5 cm H2O) as defined by the Berlin definition. The reported usual duration of ECMO in these patients is 7-10 days. However, increasing reports of prolonged duration ECMO (>14 days) for respiratory failure document survival rates of 50-70% with native lung recovery, and ECMO bridge to lung transplantation has been performed at many centers. At present, there are no established national criteria for when to consider futility or lung transplantation in adult patients requiring ECMO for acute respiratory failure. We report a case of prolonged duration venovenous-ECMO (1,347 hours, 56.13 days), with native lung recovery and discuss treatment strategies to optimize native lung recovery in ECMO patients. The lung may have unexpected regenerative capacity with native lung recovery after prolonged mechanical support, similar to acute kidney injury and native renal recovery. We recommend redefining irreversible lung injury and futility in ECMO.
    ASAIO journal (American Society for Artificial Internal Organs: 1992) 11/2013; 59(6):642-50. DOI:10.1097/MAT.0b013e3182a9e341 · 1.39 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Not Available
    Computer Vision., Second International Conference on; 01/1989
Show more

Preview

Download
7 Downloads
Available from